Authorizing legislation - ARRA

Attachment A.2: Section of the American Recovery and Reinvestment Act of 2009
(ARRA) relevant to 0920-0852, HAI and Antimicrobial Use Prevalence Survey
The section of the Act that is relevant appears on page H.R. 1-66 (copied below):
“PREVENTION AND WELLNESS FUND
(INCLUDING TRANSFER OF FUNDS)

For necessary expenses for a ‘‘Prevention and Wellness Fund’’
to be administered through the Department of Health and Human
Services, Office of the Secretary, $1,000,000,000: Provided, That
of the amount provided in this paragraph, $300,000,000 shall be
transferred to the Centers for Disease Control and Prevention
(‘‘CDC’’) as an additional amount to carry out the immunization
program (‘‘section 317 immunization program’’) authorized by section
317(a), (j), and (k)(1) of the Public Health Service Act (‘‘PHS
Act’’): Provided further, That of the amount provided in this paragraph,
$650,000,000 shall be to carry out evidence-based clinical
and community-based prevention and wellness strategies authorized
by the PHS Act, as determined by the Secretary, that deliver
specific, measurable health outcomes that address chronic disease
rates: Provided further, That funds appropriated in the preceding
proviso may be transferred to other appropriation accounts of the
Department of Health and Human Services, as determined by the
Secretary to be appropriate: Provided further, That of the amount
appropriated in this paragraph, $50,000,000 shall be provided to
States for an additional amount to carry out activities to implement
healthcare associated infections reduction strategies: Provided further,
That not more than 0.5 percent of funds made available
in this paragraph may be used for management and oversight
expenses in the office or division of the Department of Health
and Human Services administering the funds: Provided further,
That the Secretary shall, directly or through contracts with public
or private entities, provide for annual evaluations of programs
carried out with funds provided under this heading in order to
determine the quality and effectiveness of the programs: Provided
further, That the Secretary shall, not later than 1 year after the
date of enactment of this Act, submit to the Committees on Appropriations
of the House of Representatives and the Senate, the
Committee on Energy and Commerce of the House of Representatives,
and the Committee on Health, Education, Labor, and Pensions
of the Senate, a report summarizing the annual evaluations of
programs from the preceding proviso: Provided further, That the
Secretary shall provide to the Committees on Appropriations of
the House of Representatives and the Senate an operating plan
for the Prevention and Wellness Fund prior to making any Federal
obligations of funds provided in this paragraph (excluding funds
to carry out the section 317 immunization program), but not later
than 90 days after the date of enactment of this Act, that indicates
the prevention priorities to be addressed; provides measurable goals
for each prevention priority; details the allocation of resources
within the Department of Health and Human Services; and identifies
which programs or activities are supported, including descriptions
of any new programs or activities: Provided further, That
the Secretary shall provide to the Committees on Appropriations
of the House of Representatives and the Senate a report on the

actual obligations, expenditures, and unobligated balances for each
activity funded under this heading not later than November 1,
2009, and every 6 months thereafter as long as funding provided
under this heading is available for obligation or expenditure.”

As stated in the 2009 Funding Opportunity Announcement (CI09-90701ARRA09) issued by the
Centers for Disease Control and Prevention for “American Recovery and Reinvestment Act
(ARRA) Emerging Infections Programs (EIPs) Healthcare-Associated Infections Program Innovations in the Surveillance of Mulitdrug-Resistant Organisms and Healthcare-Associated
Infections,”
“The Prevention and Wellness Fund section of ARRA provides funding to the Office of
the Secretary (OS) of the Department of Health and Human Services (HHS) to be provided to
States as an additional amount to carry out activities to reduce healthcare-associated infections.
This Funding Opportunity Announcement (FOA) describes opportunities for ARRA HAI
funding which will be awarded on behalf of the OS through CDC’s Emerging Infections
Program (EIP) cooperative agreement” (page 2).
The HAI and Antimicrobial Use Prevalence Survey is described in Activity 2D of this Funding
Opportunity Announcement: “Implement a hospital-wide HAI prevalence survey in accordance
with a multi-site protocol developed by the EIP Network” (page 7).